Is BMY or PFE cheaper?

On trailing earnings, BMY is cheaper: BMY trades at a 16.05 P/E and PFE at 20.01.

Which has grown faster, BMY or PFE?

Over the past five years, PFE grew revenue faster — BMY at a 2.52% CAGR versus PFE at 8.22%.

Does BMY or PFE pay a bigger dividend?

BMY yields 4.38% and PFE yields 6.56% based on trailing dividends and the latest price.

Is BMY or PFE more profitable?

BMY runs the higher net margin — BMY at 15.01% versus PFE at 11.83%.

Which has been the better investment, BMY or PFE?

Over the past 10-year, PFE delivered the higher annualized total return — BMY at 1.08% versus PFE at 2.13%. Past performance doesn't predict future results.

Bristol-Myers Squibb Company (BMY) vs Pfizer Inc. (PFE)

BMY leads on 10 of 13 compared metrics.

A side-by-side comparison of Bristol-Myers Squibb Company and Pfizer Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 13, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

BMY

Bristol-Myers Squibb Company

Total return — BMY vs PFE

growth of $100 · last 30y

BMY +171.1%PFE +128.5%BMY compounded faster

BMY PFE

BMY vs PFE: by the numbers

•PFE is the larger company ($149.38B vs $116.66B market cap).
•BMY trades at the lower earnings multiple (16.05 vs 20.01 P/E).
•BMY converts more revenue to profit (15.01% vs 11.83% net margin).
•PFE grew revenue faster over the past five years (8.22% vs 2.52% CAGR).
•PFE pays the higher dividend yield (6.56% vs 4.38%).

Which is better, BMY or PFE?

Metric tally: BMY 10 · PFE 3

It depends on what you're optimizing for:

ValueBMY(lower P/E)

GrowthPFE(faster 5Y revenue CAGR)

IncomePFE(higher dividend yield)

QualityBMY(higher ROIC)

Valuation

Metric	BMY	PFE
P/E ratio	16.05●	20.01
Forward P/E	9.31	9.25
P/S ratio	2.41	2.37
P/B ratio	5.82	1.67●
PEG ratio	1.71	—
EV / EBITDA	11.03●	12.72
FCF yield	10.20%●	6.31%

Profitability

Metric	BMY	PFE
Gross margin	68.75%	69.35%
Operating margin	25.67%●	23.45%
Net margin	15.01%●	11.83%
ROE	36.25%●	8.31%
ROIC	13.90%●	8.84%

Dividends

Metric	BMY	PFE
Dividend yield	4.38%	6.56%●
Payout ratio	72.25%	126.47%

Growth (annualized)

Metric	BMY	PFE
Revenue CAGR (5Y)	2.52%	8.22%●
EPS CAGR (5Y)	9.38%●	-3.78%
FCF CAGR (5Y)	-2.50%●	-3.79%
Total return CAGR (5Y)	0.74%●	-3.33%

Frequently asked

Which is better, BMY or PFE?: It depends on your goal. value: BMY (lower P/E); growth: PFE (faster 5Y revenue CAGR); income: PFE (higher dividend yield); quality: BMY (higher ROIC). Across all compared metrics, BMY leads 10 to 3.
Is BMY or PFE cheaper?: On trailing earnings, BMY is cheaper: BMY trades at a 16.05 P/E and PFE at 20.01.
Which has grown faster, BMY or PFE?: Over the past five years, PFE grew revenue faster — BMY at a 2.52% CAGR versus PFE at 8.22%.
Does BMY or PFE pay a bigger dividend?: BMY yields 4.38% and PFE yields 6.56% based on trailing dividends and the latest price.
Is BMY or PFE more profitable?: BMY runs the higher net margin — BMY at 15.01% versus PFE at 11.83%.
Which has been the better investment, BMY or PFE?: Over the past 10-year, PFE delivered the higher annualized total return — BMY at 1.08% versus PFE at 2.13%. Past performance doesn't predict future results.

Go deeper

Full BMY analysis Full PFE analysis Interactive comparison tool

Dig into the metrics

Bristol-Myers Squibb P/E ratio Pfizer P/E ratio Bristol-Myers Squibb dividend yield Pfizer dividend yield Bristol-Myers Squibb ROE Pfizer ROE Bristol-Myers Squibb operating margin Pfizer operating margin Bristol-Myers Squibb revenue growth Pfizer revenue growth Bristol-Myers Squibb free cash flow Pfizer free cash flow

Bristol-Myers Squibb & Pfizer appear in these rankings

Highest Dividend Yield Stocks Highest ROE Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 13, 2026.